Location History:
- Hod-Hasheron, IL (1998)
- Hod Hasharon, IL (1994 - 2004)
Company Filing History:
Years Active: 1994-2004
Title: Yair Aharonowitz: Innovator in Antimicrobial Research
Introduction
Yair Aharonowitz is a notable inventor based in Hod Hasharon, Israel. He has made significant contributions to the field of antimicrobial agents, holding a total of 4 patents. His work focuses on the development of innovative solutions to combat bacterial infections.
Latest Patents
Aharonowitz's latest patents include groundbreaking research on recombinant Staphylococcus thioredoxin reductase and inhibitors thereof, which are useful as antimicrobial agents. This patent provides isolated and purified Staphylococcus thioredoxin reductases (TrxB), along with polynucleotides encoding the TrxBs, vectors, and host cells containing such polynucleotides. Additionally, it includes antibodies reactive with the TrxBs, methods for isolating the TrxBs, and techniques for producing recombinant TrxBs. His work also involves using TrxBs for screening compounds for TrxB-modulating activity and detecting Staphylococcus in test samples. Another significant patent involves a new oxido reductase enzyme system obtainable from Penicillium chrysogenum, which is involved in the production of β-lactams. This patent discloses a set of genes encoding the enzyme activity and methods to enhance production using the oxido reductase system.
Career Highlights
Throughout his career, Aharonowitz has worked with prominent companies, including Gist-Brocades N.V. and Gist-Brocades B.V. His experience in these organizations has contributed to his expertise in the field of biotechnology and antimicrobial research.
Collaborations
Aharonowitz has collaborated with notable individuals in his field, including Gerald Cohen and Rachel Schreiber. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Yair Aharonowitz is a distinguished inventor whose work in antimicrobial research has led to valuable patents and advancements in the field. His contributions continue to impact the development of effective antimicrobial agents.